Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel Diseases
NCT ID: NCT04488198
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2019-03-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Hypnosis in Pediatric Crohn's Disease
NCT03809195
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
NCT04779307
Effect of Acupuncture on Patients With Crohn's Disease in Remission
NCT04211129
Effect of Acupuncture on Mild to Moderate Active Crohn's Disease
NCT04187820
Effect of Acupuncture on Quiescent Crohn's Disease
NCT04198831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
20 CIBD patients do not receive acupuncture or placebo-acupuncture.
No interventions assigned to this group
Acupuncture group
20 CIBD patients receive 8 sessions of acupuncture therapy with 0,3 x 30mm needles (asia-med special number 16).
Acupuncture
Patients receive 8 acupuncture sessions (1 session per week, 20 minutes per session) with acupuncture needles.
Placebo group
20 CIBD patients receive 8 sessions of sham acupuncture with placebo-needles 0,3 x 30mm (Streitberger).
Placebo-Acupuncture
Patients receive 8 acupuncture sessions (1 session per week, 20 minutes per session) with placebo-needles.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture
Patients receive 8 acupuncture sessions (1 session per week, 20 minutes per session) with acupuncture needles.
Placebo-Acupuncture
Patients receive 8 acupuncture sessions (1 session per week, 20 minutes per session) with placebo-needles.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stable pharmacological treatment at least for 8 weeks
Exclusion Criteria
10 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christina Hafner
Christina Hafner
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gisela Scharbert, MD
Role: PRINCIPAL_INVESTIGATOR
MedUniVienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1773/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.